VREX · CIK 0001681622
What Varex Imaging Corp. told the SEC could break it.
Varex is squeezed by concentration on both sides of its business. Its revenue depends on a handful of large imaging OEMs — one customer (Canon) was 18% of fiscal 2025 revenue and its ten largest about 52% — and notably many of those customers are also competitors, so a cancellation or pullback by a major one has hurt results before and takes significant time to replace. On the supply side, critical components such as transistor arrays, cesium iodide coatings, specialized chips and X-ray tube targets come from single or limited-source suppliers, alongside metal raw materials. All of this sits on a globally exposed footprint — about 70% of revenue is from outside the US and manufacturing spans China, Germany, the Netherlands, the Philippines and India — where the US-China trade war has raised costs on its cross-border material flows.
4 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Customer concentration
- one customer 18% of revenue; top-10 OEM customers = ~52% of revenue (many of whom are also competitors)high
Varex's revenue is concentrated in large imaging OEMs — one customer (Canon) was 18.0% of revenue in fiscal 2025 and its ten largest customers were ~52% of revenue (53%/51% prior years), with one customer 14% of receivables; many of these OEM customers are also competitors, and because lost business takes significant time to replace, a cancellation, delay or reduction by a major OEM has materially hurt and could again hurt operating results. (Top customers captured as named edges; this records the aggregate concentration.)
“Our ten largest customers as a group accounted for approximately 52%, 53% and 51% of our revenue for fiscal years 2025, 2024 and 2023, respectively.”
SEC filing →As of 2025
Sole-source dependency
- single/limited-source suppliers for critical components (transistor arrays, cesium iodide coatings, specialized ICs, X-ray tube targets) and metal raw materialshigh
Some components in Varex's X-ray products are sourced from a limited group of suppliers or a single-source supplier — transistor arrays and cesium iodide coatings for digital detectors, specialized integrated circuits, X-ray tube targets, housings, bearings and others — and it requires metal raw materials (copper, nickel, silver, gold, lead, tungsten, iridium); loss of a sole-source supplier or a raw-material shortage could disrupt manufacturing and delivery.
“Some of the components included in our products may be sourced from a limited group of suppliers or from a single source supplier, such as transistor arrays and cesium iodide coatings for digital detectors and specialized integrated circuits, X-ray tube targets, housings, bearings, and various other components.”
SEC filing →As of 2025
Geographic concentration
- ~70% of revenue from outside the U.S.; manufacturing spread across China, Germany, Netherlands, Philippines and India; FX exposuremedium
About 70% of Varex's fiscal 2025 revenue came from customers outside the United States, and it manufactures across the U.S., Netherlands, China, Germany, the Philippines and India, exposing it to global/regional economic instability, shifting politics, tariffs and trade wars, and currency risk (a 10% adverse FX move is a ~$14.6M earnings impact).
“Revenues generated from customers located outside the United States accounted for approximately 70%, 68%, and 69% of our total revenues during fiscal years 2025, 2024, and 2023, respectively.”
Regulatory & policy
- U.S.-China trade war raising costs on bidirectional raw-material/sub-assembly/finished-goods flows; reliance on temporary tariff exclusionsmedium
Varex's business, particularly in China, has been impacted by the U.S.-China trade war — importing raw materials from China to the U.S. and importing materials/sub-assemblies and finished goods into China have all become more expensive and difficult, and competitive pressure has risen versus less-affected Asian/European rivals; tariff exclusions are only temporary and granted shipment-by-shipment, so it is implementing local-for-local sourcing and other mitigation with no guarantee of success.
“In recent years, our business, particularly in China, has been impacted by the United States-China trade war in the following ways, among others: (1) importing raw materials from China to the United States has become more expensive, (2) importing raw materials and sub-assemblies from the United States to China has become more expensive,”
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings, including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its customers
Rapiscan Systems, Inc. (OSI Systems)
“Our top five customers, measured by revenue, are Canon Medical Systems Corporation ("Canon"), United Imaging Healthcare, General Electric Company, Siemens Healthineers AG ("Siemens"), and Rapiscan Systems, Inc., which collectively accounted for approximately 40% of total revenue in fiscal year 2025.”
Cited →GE HealthCare (General Electric Company)
“Our top five customers, measured by revenue, are Canon Medical Systems Corporation ("Canon"), United Imaging Healthcare, General Electric Company, Siemens Healthineers AG ("Siemens"), and Rapiscan Systems, Inc., which collectively accounted for approximately 40% of total revenue in fiscal year 2025.”
Cited →United Imaging Healthcare
“Our top five customers, measured by revenue, are Canon Medical Systems Corporation ("Canon"), United Imaging Healthcare, General Electric Company, Siemens Healthineers AG ("Siemens"), and Rapiscan Systems, Inc., which collectively accounted for approximately 40% of total revenue in fiscal year 2025.”
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch